Am­gen can close Hori­zon deal by Sep­tem­ber if no rul­ing from courts on FTC suit

Am­gen and Hori­zon’s $28 bil­lion merg­er will be able to close on Sept. 15 if the Fed­er­al Trade Com­mis­sion’s law­suit to block the merg­er hasn’t been re­solved by that time, the biotech gi­ant said in a se­cu­ri­ties fil­ing Thurs­day.

Un­til then, the deal will be blocked from con­sum­ma­tion by court or­der. Am­gen has said pre­vi­ous­ly that it ex­pects the deal to close by the end of the year, and CEO Robert Brad­way has said that he’s “con­fi­dent” the deal will com­plete de­spite the gov­ern­ment’s ob­jec­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER